Hill Top Research, one of the leading clinical research services
companies in the US, has positioned itself for growth after last
week's acquisition by Utah's DW Healthcare Partners, a private
equity firm focused on the...
Rhodia is facing two separate investigations for alleged accounting
irregularities as well as insider trading, just as the financial
difficulties afflicting the French chemicals group have started to
abate.
Pharmaceutical distribution and technology company Cardinal Health
reported a slide in profits in the second quarter of the year, as
an internal investigation into the company's accounting practices
claimed additional executive...
Germany's MWG Biotech has said it will slash nearly two thirds of
its workforce in a further effort to reduce costs, prompting
speculation about the long-term future of the company in its
present state.
Abingworth Management, a UK venture capital group, has raised a
$350 million investment vehicle in a move that lends further weight
to suggestions that the funding crisis hitting the biotechnology
sector may be nearing its end.
US zuChem, a development-stage company that focuses on
commercialising manufacturing processes for glycochemicals, has
raised a considerable chunk of capital. Funds earmarked for
development of new sugar-based pharmaceutical intermediates.
